Transplantation of pancreatic islets is a promising therapy for the treatment of type 1 diabetes mellitus. However, long-term islet graft survival rates are still unsatisfactory low. In this study we investigated the role of cytomegalovirus (CMV) in islet allograft failure. STZ-diabetic rats received an allogenic islet graft in combination with either an acute CMV infection or control infection. A third group received ganciclovir treatment in addition to the CMV infection. Graft function was assessed by measuring basal blood glucose levels. After sacrifice, the islet grafts were retrieved for analysis of infection and leukocyte infiltration. CMV-infected recipients demonstrated accelerated islet graft failure compared to noninfected controls. CMV infection of the graft was only observed prior to complete graft failure. Quantification of the leukocyte infiltration demonstrated increased CD8 + T-cell and NK cell infiltration in the CMV-infected grafts compared to the controls. This suggests that CMV infection accelerates immune-mediated graft destruction. Antiviral ganciclovir treatment did not prevent accelerated graft failure, despite effectively decreasing the grade of infection. Our data confirm the recently published CITR data, which state that CMV is an independent risk factor for failure of islet grafts. Also, our data demonstrate that new approaches for preventing virus-induced islet allograft failure may be required.
INTRODUCTION
of these factors may lie at the basis of declining graft function (21, 46) . It is surprising that the role of cytomegalovirus (CMV) After more than three decades of research into the principle applicability of clinical islet transplantation has gained only minor attention as a contributing factor to islet graft failure. This is despite the strong correlation (3,37), a major breakthrough was achieved in 2000 by Shapiro et al. (47) , who demonstrated that insulin indebetween this viral infection and solid organ graft rejection (1, 13, 17, 24, 32, 48) . CMV is a widely spread, persispendence could be achieved by applying a glucocorticoid-free immunosuppressive regimen after grafting the tent infection, which develops asymptomatic in healthy, immunocompetent individuals (16) . In immunocompromislets into the liver of diabetic patients. This success has led to a tremendous growth in the number of clinical ized individuals, the virus may reactivate and cause mild to severe CMV disease. A secondary feature of the virus islet transplantations performed worldwide. In spite of this optimism, a number of critical issues remain to be is that its reactivation is strongly associated with allograft rejection. In solid organ transplantation, this risk solved. Islets from more than one donor are required to supply patients with sufficient graft volume (46) . Anon CMV-induced graft failure highly depends on the serostatus of both donor and recipient. The highest risk other important issue is that graft function declines in the years after transplantation, with only 20% of the paon accelerated graft failure is observed in seronegative [non-CMV-carrying (R−)[ recipients receiving a graft tients remaining insulin independent 5 years after transplantation (6,46). The exact causes of islet allograft failfrom a seropositive [CMV-carrying (D+)] donor (14) . This process appears to develop independent of inhibiure remain to be identified, but a high metabolic pressure, recurring autoimmunity, alloimmunity, or a combination tion of viral replication by antiviral medication (24, 49) . As for islet transplantation, the role of CMV in the ways exceeded the therapeutic 150 µg/L necessary for islet engraftment (43), but is sufficiently low to prevent failure of islet grafts was only recently recognized (6). The 2009 CITR report pointed to donor CMV seroposiCsA-induced islet toxicity (43). RCMV infection develops in a similar manner as tivity combined with recipient seronegativity as an independent risk factor for graft failure after islet transplan-HCMV infection in humans (51, 52) . In immunocompetent animals, the infection develops asymptomatic, whereas tation. Before this report, studies that addressed the CMV issue in islet transplantation mostly focused on the low in immunocompromized rats it develops in a generalized infection, characterized by hepatitis, splenitis, and throm-CMV seroconversion rates and the absence of CMV disease after transplantation (2, 8, 19, 20, 63) . This absence of bocytopenia (51, 52) . Since islet grafts are small in size, the transplanted viral load is considered to be low. To CMV transmission or de novo infection may be the result of adequate antiviral treatment given prophylacticmimic this clinical situation, rats received a nonlethal low-dose CMV infection of 2 × 10 5 plaque-forming units ally in the peritransplant period. Only two studies addressed the role of CMV in islet graft survival. Warnock (pfu).
The endocrine graft volume of 5 µl (57) was transet al. (60) merely suggested the negative effect of the virus on islet graft survival, whereas Eckhard et al. (12) planted under the kidney capsule to allow full retrieval and histological study of the grafts after sacrificing the found high CMV transmission rates and a trend towards reduced graft function in CMV-positive recipients after animals. Transplantation of an endocrine volume of 5 µl is generally accepted to study the effects of experimental combined islet-kidney transplantation, even when antiviral treatment was applied (12). Together with a high treatments on islet graft survival (11, 57) . Transplantation was considered successful when nonfasting blood degree of CMV mismatches between islet donors and recipients, especially the R−/D+ combination (20) , these glucose concentrations reached levels below 10 mmol/ L. One day after transplantation, the islet graft recipients studies clearly point to a role of CMV in islet graft failure.
received a CMV infection (N = 10). CMV infection at day 1 after transplantation, via intraperitoneal injection, Studies unarguably proving or excluding the deleterious effect of CMV on islet grafts and discussing its is in solid organ transplantation models generally accepted to study the effects of the virus on graft survival mechanism of action are lacking. At this point, interpretation of results from patient studies is difficult, as they (23, 25, 29) . We chose to use this model, rather than infection via the islet graft, since it allows us to control show limitations in respect to size and characteristics of the experimental groups. Therefore, we decided to the timing as well as the grade of infection. MOCKinfected, transplanted animals (N = 11) served as coninvestigate the role of CMV in islet transplantation in an acute rat infection model (i.e., a model in which CMV trols. CMV-infected and control animals were transplanted as pairs or two CMV-infected animals and one is given directly after transplantation) (23, 25, 29) . These models are generally accepted and well controlled in control. The necessary number of standardized islet grafts was prepared from one pool of isolated islets to terms of the provided viral load and the lack of overshadowing and interfering secondary infections. Further, ensure that both CMV-infected recipients and matching controls received identical islet grafts. we aimed at identifying the mechanism by which CMV exerts its effect. In addition, we mimicked the clinical Recipients of islet grafts were followed and monitored by measuring blood glucose levels, until graft failsituation, in which prophylactic ganciclovir treatment is applied to prevent CMV viremia and disease. ure occurred. Graft failure was defined as two blood glucose measurements exceeding 20 mmol/L. Six of the
MATERIALS AND METHODS
CMV-infected animals were sacrificed at the time of Study Design complete graft failure. At the same time, the matching control animals were sacrificed (N = 4). Three control Streptozotocin (STZ) diabetic Albino Oxford (AO) rats were transplanted with an islet allograft. To study animals were followed up until complete graft failure. Moreover, four CMV-infected and four matching conthe effects of CMV in islet graft survival we used a model that is generally accepted in solid organ transtrols were sacrificed at 7 days after transplantation to gain more insight in the processes underlying islet graft plantation (4,30), rather than the clinical immunosuppressive protocol, which has been demonstrated to infailure. After sacrifice, the grafts, salivary glands, and native pancreata were retrieved for immunohistochemiduce severe insulin resistance and β-cell toxicity in rats (35). In our model, a 10-day low-dose cyclosporine A cal staining. In a third experiment, the effect of antiviral treatment (CsA) immunosuppression protocol is applied, which is generally used to prevent acute rejection after solid oron the CMV-induced graft failure was investigated. To this end, a group of transplanted recipients (N = 5) regan transplantation (4, 30 Chemical Determinations blood glucose levels exceeding 20 mmol/L over a period of 2 weeks served as islet graft recipients. The absence Nonfasting blood glucose levels were determined in blood sampled from the tail vein once every 2 days. The of functional β-cells in the native pancreas, defined as less than 5% of normal controls, was always confirmed glucose concentration was determined using the AccuChek Sensor system (Roche). Two blood glucose levels after sacrifice.
exceeding 20 mmol/L in a 2-week period was considIslet Transplantation ered as reestablishment of diabetes and complete islet graft failure. Islets were isolated from pancreata of Lewis rats as previously described (10), separated from exocrine tisImmunocytochemistry sue by centrifugation over a discontinuous dextran gradient (58) and further purified by handpicking. After this At sacrifice, the kidney with the islet graft and the salivary glands were removed and snap frozen in liquid procedure, the purity of the islet graft was close to 100%. The total islet volume obtained by the isolation nitrogen. The native pancreas was removed and fixed in Bouins fixative for paraffin processing. The pancreas procedure was determined by measuring the diameters (57) of the islets in a 2% aliquot of the islet suspension.
was sectioned at 5 µm and stained with aldehyde fuchsin to determine the presence or absence of functional β-Subsequently, the total islet volume was calculated, assuming the islets to be perfect spheres. The graft volume cells.
The islet graft and the salivary glands were sectioned (5 µl) was expressed in microliters, as previously reported by our group (15, 57, 62) , which corresponds to at 5 µm, fixed for 10 min in ice-cold acetone, and air dried for histological examination. Endogenous peroxiapproximately 11,000 IEQ/ kg body weight. Transplantation under the kidney capsule was performed at the dase was blocked for 20 min in methanol (Merck, Darmstadt, Germany) containing 1% hydrogen peroxide (kidupper pole by carefully expelling the islets from a polyethylene tube introduced at the lower pole of the kidney, ney and islet graft) or in phosphate-buffered saline (PBS) containing 0.15% hydrogen peroxide (salivary glands). immediately after isolation.
Primary antibodies were incubated for 1 h, and secondImmunosuppression and Antiviral Treatment ary antibodies were incubated for 30 min. The whole procedure was performed at room temperature. Primary Rats received 5 mg/kg CsA (Sandimmune, Novartis, Basel, Switzerland) subcutaneously on a daily basis, monoclonal antibodies used were: mAb8 (1:8) (26) against RCMV R44-protein, OX35 (undiluted, ATCC) starting directly after transplantation. To prevent CsA cytotoxicity on the islet grafts (43), CsA immunosupagainst CD4, OX8 (undiluted, ATCC) against CD8, and NKRP1A (1:50) (BD Pharmingen, San Jose, CA) against pression was stopped after 10 days. This protocol has NKRP1A-positive NK cells. Secondary antibodies used counted. During analysis, the percentage of CD25 + and FoxP3 + T cells was determined based on the samples were: horseradish peroxidase-conjugated rabbit antimouse IgG1 or IgG2a (Dako, Glostrup, Denmark), and stained with the isotype controls. The isotype controls were used to set the gate, in such a way that 99% of the biotin-conjugated goat-anti-mouse IgG1 or IgG2a (Dako). Peroxidase activity was demonstrated by using 3-aminocells were negative. Then, the gate was copied to the samples stained with anti-CD25 and anti-FoxP3, and the per-9-ethyl-carbazole (Sigma), biotin labeling was demonstrated using horse-radish peroxidase conjugated Strepcentage of positive cells was determined. Data were analyzed using Winlist 5.0 software (Verity Software House). tavidin (Dako), and subsequent 3,3-diaminobenzidine (DAB) staining (Sigma). In all control sections, PBS Statistical Analysis was used instead of the primary antibody. Following Transplantation threshold was set manually, based on the negative control section, and subsequently, the total staining area was After allogenic islet transplantation, complete normeasured using Leica Qwin software. Leukocyte influx moglycemia, defined as blood glucose levels below 10 was expressed as the stained surface area as a percentage mM, was restored in 73% (8/11) of the MOCK-infected of the total surface area. Per section, the complete islet control recipients within 4 days after transplantation, graft was analyzed, which generally comprised 8-10 while only 50% (5/10) of the CMV-infected animals microscopic fields. Non-islet graft tissue, such as kidney completely restored normoglycemia within 3 days after tissue, within the analyzed field, was excluded from transplantation. The time to reach normoglycemia was analysis.
not significantly different between the CMV-infected and control animals. Body weights (MOCK 236.6 ± Flow Cytometry 18.47 g vs. CMV 248.3 ± 12.6 g) and plasma CsA levels Blood T cell subpopulations were harvested from (MOCK 1389 ± 27.97 µg/L vs. 1689 ± 302.1 µg/L) heparinized blood, sampled from the tail vein, and in were not significantly different between the MOCKsplenocytes harvested from the spleen after sacrifice.
infected and the CMV-infected animals at day 0 and day The blood sample (1 ml) was 1:1 diluted with PBS and 7 after transplantation, respectively. The animals that did centrifuged (20 min, 2,500 rpm, 4°C). The erythrocytes not reach the criteria for complete normoglycaemia did were lysed by incubation in NH 4 Cl for 10 min at 4°C.
show a reduction of blood glucose levels, demonstrating For four-color flow cytometry, 1 × 10 6 cells were rethe functionality of the transplanted islet grafts. All anisuspended in PBS containing 5% fetal calf serum (FCS) mals gained weight after islet transplantation and the and 0.1% sodium azide (PBS/FCS/azide). Cells were ingeneral health status improved. The low-dose CMV incubated with a cocktail of primary antibodies for 1 h at fection had no direct consequences for the weight develroom temperature in the dark. Primary antibodies used opment or the appearance of the animals. were: PerCP-conjugated R73 (1:100) against the rat TIslet Allograft Survival in the Presence and Absence cell receptor (BD Pharmingen), FITC-conjugated antiof a CMV Infection CD4 (BD Pharmingen), PE-conjugated anti-CD25 (BD Pharmingen), APC-conjugated anti-FoxP3 (eBioscience, Six of the CMV-infected animals were followed up until complete graft failure, as well as three MOCKSan Diego, CA), or corresponding isotype controls. The intracellular staining was performed according to the infected controls. The CMV-infected animals demonstrated significantly accelerated graft failure (p < 0.01), FoxP3 staining kit protocol (eBioscience). After staining, the cells were washed twice, resuspended in PBS/ compared to the MOCK-infected control recipients (Fig.  1A, B) . Moreover, the four controls that were sacrificed FCS/azide, and analyzed by flow cytometry (FACS Calibur, Beckton Dickinson).
at the same time of their respective CMV-infected partner did not show signs of graft failure at the time of During flow cytometry, at least 1 × 10 5 lymphocytes, based on the forward and side scatter pattern, were sacrifice (e.g., blood glucose levels >20 mM). At day 13 allografts, despite adequate levels of CsA immunosuppression.
CMV Infection of Islet Grafts and Salivary Glands
To gain more insight into the mechanism of CMVaccelerated islet graft failure, we studied the CMV infection in the islet allograft tissue and the salivary glands. To study the processes preceding graft failure, four CMV-infected and four MOCK-infected recipients were sacrificed 7 days after transplantation (i.e., before complete graft failure).
Retrieved grafts and salivary glands were stained for the presence of CMV-R44 protein (Fig. 2) . At day 7 after transplantation, as well as at the time of graft failure, all salivary glands of the CMV-infected animals demonstrated R44
+ cells ( Fig. 2A) , demonstrating the establishment of a generalized CMV infection. CMV infection of the islet grafts was demonstrated by the presence of R44
+ cells in the functioning grafts retrieved at day 7 after transplantation ( Fig. 2C) . R44
+ cells were not found in the grafts retrieved at the time of complete graft failure (Fig. 2D) . The salivary glands and grafts of noninfected control recipients were consistently negative (Fig. 2B, E, F) .
Immune Responses in the Islet Graft
Since CMV infection has previously been associated with increased immune activation and accelerated immune-mediated solid organ graft rejection (13, 24, 32, 33, 48, 59) , we studied the infiltration of the CD4 + and In all grafts, CD4 + and CD8 + T cells were observed cance was calculated using the Kaplan Meier log-rank test (**p < 0.01) (A). After transplantation, blood glucose levels (Fig. 3A, B) . T cells were found scattered throughout were reduced in both CMV-infected recipients (solid line) and the graft, but in the CMV-infected and control grafts that
MOCK-infected controls (dashed line). Blood glucose levels
were retrieved at day 13 after transplantation, T cells gradually increased, demonstrating gradual islet graft failure were also organized in dense clusters (Fig. 3A , B, de-(B). Results are depicted as the mean ± SEM.
picted by the arrows). This was not observed in the grafts retrieved at day 7 after transplantation. Also, NK cells were found scattered throughout the islet grafts (Fig. 3C) . after transplantation (i.e., the time of complete graft failure in the CMV-infected animals), all animals demonMorphometric analysis demonstrated that the number of infiltrating CD4 + T cells did not significantly change strated sufficient, nontoxic levels of CsA immunosuppression (i.e., above the therapeutic levels of 150 µg/ml) over time, nor did the number of infiltrating CD4 + T cells differ between the CMV-infected recipients and the (43). This was not significantly different between the CMV-infected recipients and the noninfected controls controls (Fig. 3A) . In the CMV-infected recipients, the number of CD8 + T cells and NK cells infiltrating the islet (controls: 335 ± 58 µg/L vs. CMV-infected recipients 334.8 ± 48.54 µg/L). These results demonstrate that grafts increased in time and was significantly increased compared to the MOCK-infected controls at the time of CMV infection impairs the functional survival of islet Figure 2 . CMV infection of islet grafts and salivary glands. Histological staining of the salivary glands showed the presence of R44 nuclear staining in the CMV-infected recipients (arrows, 40× original magnification, day 13) (A), but not in the salivary glands of MOCK-infected recipients (40× original magnification, day 13) (B). Histological staining of the islet allografts demonstrated R44 + cells in the grafts retrieved at day 7 after transplantation (C), but not in the grafts retrieved at the day of complete graft failure (e.g., day 13 after transplantation) (20× original magnification) (D). Islet graft tissue of the MOCK-infected control animals was consistently negative (E, F) (20× original magnification). Histological panels show grafts representative for the analyzed groups.
complete graft failure (CD8 T cells, p < 0.05, NK cells, different time points after transplantation. As a measure for immune activation, the proportion of FoxP3 − p < 0.01) (Fig. 3B and C Allograft Function Although it did not reach statistical significance, the increased ratio between CD4 effector T cells and regulaSince it is thought that a generalized systemic CMV infection is a requirement for CMV-induced effects on tory T cells in the CMV-infected recipients could be attributed to both a decreased frequency of regulatory T islet grafts, we questioned whether antiviral treatment of 
) (A). Grafts demonstrated somewhat increased infiltration of CD8
+ T cells in CMV-infected animals (solid bars) compared to control animals (white bars) at day 7 after transplantation and significantly increased infiltration at day 13 after transplantation (p < 0.05) (B). Infiltration of NKRP1A + NK cells was significantly increased in the islet grafts of CMV-infected animals compared to control animals at day 13 after transplantation (p < 0.05) (C). Results are depicted as median and quartiles. Statistical significance was calculated using the Mann-Whitney U-test (E). *p < 0.05. the CMV infection could prevent CMV-accelerated graft ical effects can be identified, which could be missed in more latent, chronic infection models. In order to deterfailure. To this end, an additional group of islet graft recipients was studied, which received ganciclovir treatmine the deleterious effects of CMV infection on islet grafts, it is necessary to use a controllable infection ment in addition to a CMV infection.
Following islet transplantation, 80% (4/5) ganmodel. For the present experiments, we therefore chose to induce the CMV infection systemically, rather than ciclovir-treated CMV-infected islet graft recipients restored normoglycemia. This was a higher survival rate via the islet graft itself. It might be argued that, due to the systemic CMV infection, the infection-induced islet compared to the nontreated CMV-infected group, but this did not reach statistical significance. The animals graft failure is not of any clinical relevance, since systemic viremia is rarely observed after clinical islet transthat successfully restored normoglycemia demonstrated similar islet graft failure rates as the nontreated CMVplantation (2,6,8, 19, 20, 63) . However, the absence of systemic viremia after clinical islet transplantation may infected recipients, which was significantly accelerated compared to the MOCK-infected controls (p < 0.05 ganbe directly attributed to the use of ganciclovir prophylaxis (2,6, 19, 20) . However, when we studied the effects ciclovir-treated recipients vs. controls, CMV-infected recipients vs. ganciclovir-treated recipients not significant, of ganciclovir in combination with a CMV infection, we also found a reduction in graft survival, despite the suclog-rank test) (Fig. 4) .
After sacrifice, R44 + cells were observed in the salicessful suppression of systemic infection. Thus, according to these results, systemic CMV infection is not an vary glands, but the number was low and in most animals absent, illustrating the efficacy of the treatment.
absolute requirement for CMV-induced accelerated islet graft failure. We therefore feel that our observations are R44 + cells were not observed in the retrieved islet grafts (not shown). Systemically, ganciclovir treatment was of great clinical relevance. Our experimental rat study demonstrated accelerated not able to suppress CMV-induced immune activation, since the ratio between CD4 effector T cells and regulagraft failure and enhanced immune activation and infiltration in the CMV-infected recipients compared to nontory T cells increased in a similar manner as in the CMV-infected recipients that did not receive ganciclovir infected controls. This corroborates the results presented in the 2009 CITR report (6), which states that also hu-[from 3.50 (2.05-4.19) 1 day prior to transplantation to 5.26 (5.05-6.29) at day 13 after transplantation (p < man islet graft failure is accelerated in the presence of a CMV infection. Furthermore, we demonstrated that gan-0.05)]. In contrast to the systemic circulation, we found an effect of the ganciclovir treatment on the CMV-induced ciclovir treatment, which is routinely applied after clinical islet transplantation (46), did not prolong the funcinfiltration of leukocytes in the graft. In all ganciclovirtreated recipients we found CD4 + and CD8 + T cells, as tional survival of islet allografts. The results from the present study suggest that several mechanisms of graft well as NK cells, but ganciclovir treatment decreased the infiltration of CD8 + T cells to the levels observed in failure may be involved, which will be outlined below. Although the infectability of islet grafts was demon-MOCK-infected controls (Fig. 4B) . The infiltration of NK cells was even less than observed in the CMVstrated by the presence of R44 + cells in the grafts retrieved 6-7 days prior to complete graft failure, the infected recipients (p < 0.05) or MOCK-infected controls (p < 0.05) (Fig. 4B) .
number of infected cells appeared to be too low to support complete graft failure based on cytolytic infection In conclusion, these data demonstrate that ganciclovir treatment can prevent systemic CMV infection and dialone. This finding suggests that CMV infection may have direct deleterious effects, but also that other mechrect infection of the islet graft, but it does not have an effect on CMV-accelerated islet graft failure or systemic anisms of graft failure are involved. This is substantiated by the observation that treatment of the infection reimmune activation.
markably reduced the number of infected cells, but DISCUSSION could not prevent accelerated graft failure. Many studies have demonstrated CMV-induced solid In search of factors determining islet graft failure, we studied the effect of CMV on the functional survival of organ graft failure via intragraft inflammation and consequently accelerated graft rejection (27, 36, 42, 55, 56) . islet allografts. We applied a generally accepted model in solid organ transplantation (4,30). In the present study Our study demonstrated that this not only holds true for solid organ grafts, but also for the failure of cellular islet we demonstrate that this model is also very suitable for studying the deleterious effects of acute CMV infection allografts. In solid organ transplantation, the accelerated rejection is interpreted as the result of local CMV-induced on cellular grafts, such as pancreatic islet grafts. An advantage of this model is that the mechanisms involved changes, such as increased MHC, adhesion molecule, or chemokine expression, with increased immune cell infilin CMV-induced graft failure can be studied in a short time frame, in a controllable manner and that acute, crittration and subsequent allograft rejection as a conse- quence (27, 36, 42, 55, 56) . The marked systemic immune ous CMV-induced effects in the islet graft. This was demonstrated in the 2009 CITR report, which negatively activation, combined with the increased infiltration of CD8 + T cells and NK cells in the grafts of the CMVcorrelated CMV infection to islet graft failure after transplantation. Interestingly, this effect of CMV was infected recipients, suggests that also in islet transplantation, CMV-enhanced immune responses against the islet found using a transplantation protocol that routinely uses ganciclovir prophylaxis (46) to prevent systemic viremia allograft may act in concert with direct CMV infection of the graft to induce islet graft failure. This is in line and clinical signs of CMV infection. Treatment of clinically active CMV infection with ganciclovir may revert with our previous data demonstrating that rat pancreatic β-cells are not only directly susceptible to RCMV infecislet allograft dysfunction, as suggested by a case report (8). However, subclinical CMV infection may occur tion, but that the infection also markedly enhanced the cellular immunogenicity (50) . This was characterized by even during ganciclovir treatment (18), and may be interfering with islet graft function. That low-grade CMV the increased expression of both classical and nonclassical MHC I molecules and the adhesion molecules ICAMinfection may still affect islet graft survival is corroborated by our finding that ganciclovir is ineffective in pre-1 and LFA-3 (50). In a study using HCMV and human β-cells, similar results were found (Smelt et cal CMV infection may be an important factor contributing to islet graft loss. The presence of elevated numbers of NK cells in the CMV-infected grafts warrants some further consider-
In our experiments, all animals that demonstrated early graft loss (i.e., CMV-infected animals) demonation. In the CMV-infected recipients, these NK cells may be primarily responding to the presence of CMV in strated systemic immune activation. This activation was characterized by increased effector T-cell versus regulathe graft (31) , but the presence of NK cells in the grafts of the noninfected controls suggests that these cells may tory T-cell ratios. This systemic immunoactivation developed independent of viral inhibition by ganciclovir, also have a role in the immune response directed against the islet allograft. Recently, NK cells with a specific alsuggesting that systemic CMV infection and subclinical CMV infection are equally able to skew the immune loreactivity have been described in solid organ transplantation (28, 38, 40) . Since NK cells are inhibited by response towards activation. In what manner systemic immune activation affects islet graft rejection remains to "self" MHC I, the lack of "self" MHC I on the islet allografts may contribute to NK cell activation and probe identified. The pronounced systemic immune response in the ganciclovir-treated animals in the absence inflammatory and destructive NK cell effector functions. Increased infiltration of NK cells in the CMV-infected of increased immune cell infiltration in the grafts is an observation we cannot explain. We speculate that ganislet grafts, as a result of graft infection and/or infectioninduced increased local immunogenicity (50) , may subciclovir may have direct effects on the islet graft by affecting local responses. Alternatively, ganciclovir may sequently further enhance the ongoing alloimmune response, accelerating the rejection process. have more systemical effects, which may interfere with islet graft survival. Such effects, however, are not apparOur finding that antiviral treatment, using ganciclovir, does not prolong graft survival is corroborated by sevent from the literature, in which ganciclovir is routinely used after clinical islet transplantation. Future research eral studies that found similar results after solid organ transplantation (24, 49) . This suggests that the immediefforts will focus on the effects of ganciclovir on islet graft function and survival. At this point, we interpret ate-early stages of viral infection, which are not affected by ganciclovir (7,39), are highly contributing to accelerour observation as a suggestion that not only the "classical" immunological rejection pathway, but other also ated graft failure. This may also hold true in this islet transplantation model, since Hayashi et al. (22) demonpathways [either immunological or non-immunological (9)] contribute to the early loss of islet grafts in these strated that even low-grade infection of immunocompetent mice had direct effects on the β-cell insulin secrerecipients. Clinically, the leading dogma has been that CMV intory capacity and inflammation of the native islets. Moreover, after islet transplantation in humans, systemic fection was a negligible factor contributing to islet graft failure. Only recently, with the publication of the 2009 viremia may not be an absolute requirement for deleteri-CITR report (6), this opinion has started to change. It it would also be of interest to study the effects of a CMV infection derived from the recipient, rather than the dohas always been assumed that islet grafts were relatively uninfectable and contained only low amounts or no virus nor. Also, the impact of a delayed CMV infection on graft function and survival should be established. The particles at all. This led to the assumption that transmission of the infection after islet transplantation, as well finding that ganciclovir did not prolong the survival of islet allografts, despite effectively reducing the magnias secondary CMV-induced effects on graft survival, was rare to nonexistent. The results from the present tude of viral infection, suggests that also low-grade CMV infection should be considered as a serious deletestudy argue against this clinical reasoning, since we demonstrated that at least several cell types within the rious factor in islet transplantation. Our data suggest that more effective suppression of CMV infections in islet islet grafts are able to support viral infection and replication. These may also be the pancreatic β-cells, since we allograft recipients may contribute to prolongation of islet graft function. have previously demonstrated that pancreatic β-cells are able to support all stages of viral replication in vitro
